Abstract
The number of bariatric operations performed each year is growing continuously and it is to be assumed that this trend will continue during the coming years. Furthermore, we will probably experience a surge of metabolic operations in the near future [1-4].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Levy P, Bonsignore MR, Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 2009; 34:243–60.
Redon J, Cifkova R, Laurent S, et al. The metabolic syndrome in hypertension: European society of hypertension position statement. J Hypertens 2008; 26:1891–900.
Valdivielso P, Sanchez-Chaparro MA, Calvo-Bonacho E, et al. Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: Results of the ICARIA study. Atherosclerosis 2009.
Temelkova-Kurktschiev T, Hanefeld M. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/ low high-density lipoprotein syndrome in type 2 diabetes. Exp Clin Endocrinol Diabetes 2004; 112:75–9.
Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006; 40 Suppl 1:S5–10.
Foster GD, Wyatt HR, Hill JO, et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 2003; 348: 2082–90.
Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. Jama 2005; 293:43–53.
Stern L, Iqbal N, Seshadri P, et al. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med 2004; 140:778–85.
Church TS, Earnest CP, Skinner JS, Blair SN. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. Jama 2007; 297:2081–91.
Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup AV. [A meta-analysis of the efficacy and safety of the anti-obesity agent Rimonabant]. Ugeskr Laeger 2007; 169:4360–3.
Erondu N, Addy C, Lu K, et al. NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine. Obesity (Silver Spring) 2007; 15:2027–42.
Gantz I, Erondu N, Mallick M, et al. Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults. J Clin Endocrinol Metab 2007; 92:1754–7.
Sloth B, Holst JJ, Flint A, Gregersen NT, Astrup A. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. Am J Physiol Endocrinol Metab 2007; 292:E1062–8.
Sloth B, Davidsen L, Holst JJ, Flint A, Astrup A. Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males. Am J Physiol Endocrinol Metab 2007; 293:E604–9.
Moy J, Pomp A, Dakin G, Parikh M, Gagner M. Laparoscopic sleeve gastrectomy for morbid obesity. Am J Surg 2008; 196:e56–9.
Suter M, Jayet C, Jayet A. Vertical banded gastroplasty: long-term results comparing three different techniques. Obes Surg 2000; 10:41–6; discussion 47.
Baltasar A, Serra C, Perez N, Bou R, Bengochea M, Ferri L. Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg 2005; 15:1124–8.
del Amo DA, Diez MM, Guedea ME, Diago VA. Vertical banded gastroplasty: is it a durable operation for morbid obesity? Obes Surg 2004; 14:536–8.
Favretti F, Cadiere GB, Segato G, et al. Laparoscopic Adjustable Silicone Gastric Banding: Technique and Results. Obes Surg 1995; 5:364–371.
Favretti F, Cadiere GB, Segato G, et al. Laparoscopic Placement of Adjustable Silicone Gastric Banding: Early Experience. Obes Surg 1995; 5:71–73.
Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg 1998; 8:267–82.
Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998; 22:947–54.
Marceau P, Biron S, Bourque RA, Potvin M, Hould FS, Simard S. Biliopancreatic Diversion with a New Type of Gastrectomy. Obes Surg 1993; 3:29–35.
Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg 1998; 22:936–46.
Brolin RE, Kenler HA, Gorman JH, Cody RP. Long-limb gastric bypass in the superobese. A prospective randomized study. Ann Surg 1992; 215:387–95.
Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg 2001; 11:276–80.
Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357:741–52.
Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357:753–61.
Sundbom M, Karlson BM. Low Mortality in Bariatric Surgery 1995 Through 2005 in Sweden, in Spite of a Shift to More Complex Procedures. Obes Surg 2008.
Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222:339–50; discussion 350–2.
Hickey MS, Pories WJ, MacDonald KG, Jr., et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg 1998; 227:637–43; discussion 643–4.
Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 2002; 236:554–9.
Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244:741–9.
Lamounier RN, Pareja JC, Tambascia MA, Geloneze B. Incretins: clinical physiology and bariatric surgery--correlating the enteroendocrine system and a potentially anti-dysmetabolic procedure. Obes Surg 2007; 17:569–76.
Katergari SA, Milousis A, Pagonopoulou O, Asimakopoulos B, Nikolettos NK. Ghrelin in pathological conditions. Endocr J 2008; 55:439–53.
Mognol P, Chosidow D, Marmuse JP. Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg 2005; 15:1030–3.
Weiner RA, Weiner S, Pomhoff I, Jacobi C, Makarewicz W, Weigand G. Laparoscopic sleeve gastrectomy--influence of sleeve size and resected gastric volume. Obes Surg 2007; 17:1297–305.
Fobi MA. Placement of the GaBP ring system in the banded gastric bypass operation. Obes Surg 2005; 15:1196–201.
Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am 1967; 47:1345–51.
Mason EE, Doherty C, Cullen JJ, Scott D, Rodriguez EM, Maher JW. Vertical gastroplasty: evolution of vertical banded gastroplasty. World J Surg 1998; 22:919–24.
Capella JF, Capella RF. The weight reduction operation of choice: vertical banded gastroplasty or gastric bypass? Am J Surg 1996; 171:74–9.
Fobi MA. Vertical Banded Gastroplasty vs Gastric Bypass: 10 years follow-up. Obes Surg 1993; 3:161–164.
Howard L, Malone M, Michalek A, Carter J, Alger S, Van Woert J. Gastric Bypass and Vertical Banded Gastroplasty- a Prospective Randomized Comparison and 5-Year Follow-up. Obes Surg 1995; 5:55–60.
Langer FB, Bohdjalian A, Felberbauer FX, et al. Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg 2006; 16:166–71.
Fobi M, Lee H, Igwe D, et al. Band erosion: incidence, etiology, management and outcome after banded vertical gastric bypass. Obes Surg 2001; 11:699–707.
Meir E, Van Baden M. Adjustable silicone gastric banding and band erosion: personal experience and hypotheses. Obes Surg 1999; 9:191–3.
Ueda K, Gagner M, Milone L, Bardaro SJ, Gong K. Sleeve gastrectomy with wrapping using polytetrafluoroethylene to prevent gastric enlargement in a porcine model. Surg Obes Relat Dis 2008; 4:84–90.
Weiner RA, Korenkov M, Matzig E, Weiner S, Karcz WK, Junginger T. Early results with a new telemetrically adjustable gastric banding. Obes Surg 2007; 17:717–21.
Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg 2008; 18:1611–7.
Fobi M. Banded gastric bypass: combining two principles. Surg Obes Relat Dis 2005; 1:304–9.
Schrag HJ, Ruthmann O, Doll A, Goldschmidtboing F, Woias P, Hopt UT. Development of a novel, remote-controlled artificial bowel sphincter through microsystems technology. Artif Organs 2006; 30:855–62.
Xu J, McNearney TA, Chen JD. Gastric/intestinal electrical stimulation modulates appetite regulatory peptide hormones in the stomach and duodenum in rats. Obes Surg 2007; 17:406–13.
Wang GJ, Yang J, Volkow ND, et al. Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry. Proc Natl Acad Sci U S A 2006; 103:15641–5.
Xu L, Sun X, Tang M, Chen JD. Involvement of the hippocampus and neuronal nitric oxide synapse in the gastric electrical stimulation therapy for obesity. Obes Surg 2009; 19:475–83.
Xu L, Sun X, Tang M, Chen JD. Involvement of the Hippocampus and Neuronal Nitric Oxide Synapse in the Gastric Electrical Stimulation Therapy for Obesity. Obes Surg 2008.
Bohdjalian A, Prager G, Aviv R, et al. One-year experience with Tantalus: a new surgical approach to treat morbid obesity. Obes Surg 2006; 16:627–34.
Champion JK, Williams M, Champion S, Gianos J, Carrasquilla C. Implantable gastric stimulation to achieve weight loss in patients with a low body mass index: early clinical trial results. Surg Endosc 2006; 20:444–7.
Cigaina V. Gastric pacing as therapy for morbid obesity: preliminary results. Obes Surg 2002; 12 Suppl 1:12S–16S.
Cigaina V, Hirschberg AL. Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin. Obes Res 2003; 11:1456–62.
Cigaina V. Long-term follow-up of gastric stimulation for obesity: the Mestre 8-year experience. Obes Surg 2004; 14 Suppl 1:S14–22.
D'Argent J. Gastric electrical stimulation as therapy of morbid obesity: preliminary results from the French study. Obes Surg 2002; 12 Suppl 1:21S–25S.
De Luca M, Segato G, Busetto L, et al. Progress in implantable gastric stimulation: summary of results of the European multicenter study. Obes Surg 2004; 14 Suppl 1:S33–9.
Favretti F, De Luca M, Segato G, et al. Treatment of morbid obesity with the Transcend Implantable Gastric Stimulator (IGS): a prospective survey. Obes Surg 2004; 14:666–70.
Hoeller E, Aigner F, Margreiter R, Weiss H. Intragastric stimulation is ineffective after failed adjustable gastric banding. Obes Surg 2006; 16:1160–5.
Shikora En. "What are the yanks doing?" the U.S. experience with implantable gastric stimulation (IGS) for the treatment of obesity - update on the ongoing clinical trials. Obes Surg 2004; 14 Suppl 1:S40–8.
Shikora SA. Implantable Gastric Stimulation - the surgical procedure: combining safety with simplicity. Obes Surg 2004; 14 Suppl 1:S9–13.
Shikora SA, Bergenstal R, Bessler M, et al. Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial. Surg Obes Relat Dis 2009; 5:31–7.
Bugajski AJ, Gil K, Ziomber A, Zurowski D, Zaraska W, Thor PJ. Effect of long-term vagal stimulation on food intake and body weight during diet induced obesity in rats. J Physiol Pharmacol 2007; 58 Suppl 1:5–12.
Sobocki J, Fourtanier G, Estany J, Otal P. Does vagal nerve stimulation affect body composition and metabolism? Experimental study of a new potential technique in bariatric surgery. Surgery 2006; 139:209–16.
Pardo JV, Sheikh SA, Kuskowski MA, et al. Weight loss during chronic, cervical vagus nerve stimulation in depressed patients with obesity: an observation. Int J Obes (Lond) 2007; 31:1756–9.
Sani S, Jobe K, Smith A, Kordower JH, Bakay RA. Deep brain stimulation for treatment of obesity in rats. J Neurosurg 2007; 107:809–13.
Halpern CH, Wolf JA, Bale TL, et al. Deep brain stimulation in the treatment of obesity. J Neurosurg 2008; 109:625–34.
Tarnoff M, Shikora S, Lembo A, Gersin K. Chronic in-vivo experience with an endoscopically delivered and retrieved duodenaljejunal bypass sleeve in a porcine model. Surg Endosc 2008; 22:1023–8.
Tarnoff M, Shikora S, Lembo A. Acute technical feasibility of an endoscopic duodenal-jejunal bypass sleeve in a porcine model: a potentially novel treatment for obesity and type 2 diabetes. Surg Endosc 2008; 22:772–6.
Gersin KS, Keller JE, Stefanidis D, et al. Duodenal- jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov 2007; 14:275–8.
Rodriguez-Grunert L, Galvao Neto MP, Alamo M, Ramos AC, Baez PB, Tarnoff M. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis 2008; 4:55–9.
Tarnoff M, Rodriguez L, Escalona A, et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc 2009; 23:650–6.
Santoro S, Malzoni CE, Velhote MC, et al. Digestive Adaptation with Intestinal Reserve: a neuroendocrine-based operation for morbid obesity. Obes Surg 2006; 16:1371–9.
Boza C, Gagner M, Devaud N, Escalona A, Munoz R, Gandarillas M. Laparoscopic sleeve gastrectomy with ileal transposition (SGIT): A new surgical procedure as effective as gastric bypass for weight control in a porcine model. Surg Endosc 2008; 22:1029–34.
Mason EE. Ileal [correction of ilial] transposition and enteroglucagon/ GLP-1 in obesity (and diabetic?) surgery. Obes Surg 1999; 9:223–8.
Cohen RV, Schiavon CA, Pinheiro JS, Correa JL, Rubino F. Duodenal- jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22–34 kg/m2: a report of 2 cases. Surg Obes Relat Dis 2007; 3:195–7.
Mingrone G, DeGaetano A, Greco AV, et al. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia 1997; 40:599–605.
Noya G, Cossu ML, Coppola M, et al. Biliopancreatic diversion preserving the stomach and pylorus in the treatment of hypercholesterolemia and diabetes type II: results in the first 10 cases. Obes Surg 1998; 8:67–72.
Arner P, Pollare T, Lithell H. Different aetiologies of type 2 (noninsulin- dependent) diabetes mellitus in obese and non-obese subjects. Diabetologia 1991; 34:483–7.
Bolinder J, Lithell H, Skarfors E, Arner P. Effects of obesity, hyperinsulinemia, and glucose intolerance on insulin action in adipose tissue of sixty-year-old men. Diabetes 1986; 35:282–90.
Kolterman OG, Gray RS, Griffin J, et al. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest 1981; 68:957–69.
Elton CW, Tapscott EB, Pories WJ, Dohm GL. Effect of moderate obesity on glucose transport in human muscle. Horm Metab Res 1994; 26:181–3.
Melton LJ, 3rd, Palumbo PJ, Dwyer MS, Chu CP. Impact of recent changes in diagnostic criteria on the apparent natural history of diabetes mellitus. Am J Epidemiol 1983; 117:559–65.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Marjanovic, G., Karcz, W.K. (2012). Perspectives of Metabolic Surgery. In: Karcz, W.K., Thomusch, O. (eds) Principles of Metabolic Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02411-5_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-02411-5_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02410-8
Online ISBN: 978-3-642-02411-5
eBook Packages: MedicineMedicine (R0)